English | Español
Erianne Leatherman | Apr 12, 2017

CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency

Robert Hadley | Apr 11, 2017

Eli Lilly donates $194,000 to aid diabetes education programs, scholarships
+ Regulatory
Keri Carbaugh | Apr 11, 2017

Proposed rule changes aimed at improving 2018 health insurance choices
+ Regulatory
John Breslin | Apr 11, 2017

Cancer patient advocates watch health care debate to ensure access to coverage
+ Technology/Innovation
LocalLabs News Service | Apr 10, 2017

Oral medication reduced psoriasis symptoms, study says
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
+ Community
Gene Johnson | Apr 10, 2017

Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
+ Technology/Innovation
Robert Hadley | Apr 10, 2017

New thyroid cancer test moves closer to earn patent protection

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes